stockrow
Friday 6 November 2026
Export MANE’s income statement to Excel — free account
Veradermics Incorporated
MANE Healthcare Biotechnology
138.19
9.59
+7.46%
Follow MANE
Alert me
| Older periods | Jun '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+2 more TTM periods Free account |
— | — | — | 0.00% | |
| — | — | 0.00% | (20.86%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
— | 0.00% | 0.00% | (10.59%) | |
Free Cash Flow per Share |
0.00 | 0.00 | (5.36) | (3.04) | |
Free Cash Flow |
— | (124.29) | (121.73) | (122.97) | |
Capital Expenditures |
— | (0.04) | — | (0.06) | |
| Other line items | |||||
Cash ROIC |
0.00% | (596.19%) | (15.58%) | (7.53%) | |
Average Days of Payables |
— | 0.00 | 0.00 | 0.00 | |
Tax Rate |
— | — | — | 0.00 | |
Research and Development Expense of Revenue |
— | — | — | 0.00% | |
Selling, General and Administrative Expense of Revenue |
— | — | — | 0.00% | |
Share Based Compensation of Revenue |
— | — | — | 0.00% | |
Operating CF/Net income |
— | 0.00 | 0.00 | 1.43 | |
Depreciation/Fixed assets |
— | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
— | 0.00 | — | 0.00 | |
Revenue per Share |
0.00 | — | 0.00 | 0.00 | |
Operating CF per Share |
0.00 | 0.00 | (5.36) | (3.04) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
— | 0.00 | — | 0.00 |
Columns are period end dates · fundamentals updated 25 Oct 2026